As part of our global expansion strategy for the FDA-cleared JAZBI™ bioresorbable bone void filler, SDIP Innovations has been actively engaging with international healthcare and innovation leaders through Hong Kong Science and Technology Parks (HSITP). Following the Asia Summit on Global Health (ASGH), our CTO, Dr Iman Manavitehrani, joined an expert panel welcoming an international delegation from across Australia, Canada, Japan, Singapore, Switzerland, the UK and beyond to showcase Hong Kong’s thriving life and health science ecosystem.
Building on these connections, Dr Manavitehrani also represented SDIP Innovations as part of the HSITP delegation to Dalian, led by Hong Kong Financial Secretary Mr Paul M.P. Chan, where he presented JAZBI™ to clinicians, hospitals and industry stakeholders. These engagements reflect our commitment to advancing regenerative medicine through international collaboration and expanding access to innovative biomaterial technologies worldwide.